A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

Proposed merger with OrthoCellix aims to create a Nasdaq-listed company focused on late clinical-stage regenerative cell therapies, enhancing market visibility and appeal to investors.

Potential Positives. Partnership with Nasdaq Private Market enhances transparency and valuation visibility for private, pre-IPO companies, addressing critical market challenges.

CACI is a member of the Fortune 500™ list of largest companies, the Russell 1000 Index, and the S&P MidCap 400 Index. For more information, visit us at www.caci.com .

ARKO Corp. (Nasdaq: ARKO) is a Fortune 500 company that owns 100% of GPM Investments, LLC and is one of the largest operators of convenience stores and wholesalers of fuel in the United States.

--Alignment Healthcare, Inc. has been named to the 2025 Fortune 1000 list, marking its debut among the top U.S. public companies ranked by total revenue. "Being named to the Fortune 1000 reflects ...

Adams has served as Cortigent’s CEO since 2023, and prior to joining Cortigent, he founded and was CEO of BioVie Inc., a Nasdaq-listed biopharmaceutical company.